5-羟甲基胞嘧啶的研究进展

CpG二核苷酸中胞嘧啶的甲基化形式5-甲基胞嘧啶(5-methylcytosine, 5mC)在哺乳动物中是一种常见的表观遗传修饰, 在基因表达调控、发育调节、基因组印迹等方面发挥重要作用。近3年来研究发现, 除了5mC外, 胞嘧啶碱基的另一种修饰-5-羟甲基胞嘧啶(5-hydroxymethylcytosine, 5hmC)在哺乳动物的多种组织中有着丰富的表达, 它可能与5mC有着不同的生物学功能。文章就近年来5hmC的研究进展进行了综述。     

表观遗传学新视点——DNA羟甲基化

5-羟甲基胞嘧啶（5hmC）是新发现的一种的修饰碱基,以低水平存在于哺乳动物的多种细胞类型中。5hmC是10-11易位（TET）家族的酶通过氧化5-甲基胞嘧啶（5mC）产生的。5hmC不仅能够降低MeCP蛋白的甲基化结合结构域（MBD）与甲基化DNA的亲和性,具有潜在的参与基因表达调控的转录调节功能,而且参与了DNA去甲基化过程。因此关于5hmC的研究日益受到学者们的青睐,随着5hmC甲基化分析和检测方法学日益发展,发现5hmC分布具有组织特异性,并且5hmC在肿瘤组织中含量显著降低,可能成为某些肿瘤早期诊断的分子标志物。     

表观遗传学新标记——5-羟甲基胞嘧啶检测方法的研究进展

被称为"第六种碱基"的5-羟甲基胞嘧啶(5-hydroxymethylcytosine, 5hmC),广泛分布于多种哺乳动物的组织和细胞中,与胚胎发育,神经系统功能以及肿瘤研究高度相关.与5-甲基胞嘧啶(5-methylcytosine, 5mC)相比,5hmC在组织中含量更低,难以精确的检测.随着研究的深入,5hmC参与的重要生物学作用逐渐被人们发现,同时也促使着5hmC的检测和定量方法不断发展.为了区分5hmC与其他胞嘧啶衍生物,很多利用化学或者酶学修饰实现靶向检测或非靶向富集5hmC的方法应运而生.因此,选择并发展灵敏,准确,可靠的5hmC检测技术对于表观遗传研究至关重要.本文重点综述了近年来发展起来的5hmC检测和测序技术,通过比较分析各种方法的优缺点,为研究人员选择特定合适的方法开展相关研究提供重要的参考.     

真核生物基因组DNA甲基化和去甲基化分析

DNA甲基化是真核生物的重要表观遗传修饰,如胞嘧啶C~5位甲基化5-甲基胞嘧啶(5mC)和腺嘌呤N~6位甲基化6-甲基腺嘌呤(6mA)。DNA 5mC可经Tet双加氧酶催化氧化形成5-羟甲基胞嘧啶(5hmC)、5-醛甲基胞嘧啶(5fC)和5-羧基胞嘧啶(5caC)。这些氧化产物不仅是去甲基化过程的中间体,而且也可能存在各自特有的表观调控功能。其中,5hmC异常可能和癌症相关,有可能成为疾病诊断的生物标志物。发展可靠、高灵敏和抗干扰能力强的DNA甲基化和去甲基化检测技术和方法至关重要,有助于理解甲基化和去甲基化的分子机制以及提高肿瘤的诊断水平。现针对DNA甲基化和去甲基化检测技术进行简要介绍。     

TET双加氧酶介导的主动去甲基化分子机制及功能研究

DNA甲基化作为一种重要的表观修饰,在基因表达调控及胚胎生长发育等方面起到重要作用。尽管5-甲基胞嘧啶(5mC)是一种稳定的共价修饰,但它在生物体内仍处于一个动态变化的过程,也就是说,它可能会通过某种方式发生去甲基化。而TET蛋白功能的揭示为DNA主动去甲基化提供了一条途径:TET双加氧酶可以将5mC迭代氧化形成5-羟甲基胞嘧啶(5hmC)、5-醛基胞嘧啶(5fC)和5-羧基胞嘧啶(5caC),再通过DNA糖苷酶TDG介导的碱基切除修复(base excision repair,BER)途径将5mC重新变为未修饰的胞嘧啶。随着人们对TET双加氧酶及主动去甲基化研究的深入,主动去甲基化的生物学功能也被逐渐揭示。现总结了已经揭示的主动去甲基化分子机制和生物学意义,同时,概括了本实验室近些年的研究进展。     

表观遗传新标志物5hmC的研究进展

5-羟甲基胞嘧啶(5-hydroxymethylcytosine,5hmC)作为表观遗传的新标志物,已引起人们的极大兴趣.5hmC由TET家族酶催化氧化5-甲基胞嘧啶(5-methylcytosine,5mC)产生,被称为高等生物基因组DNA的"第六碱基".5hmC不仅可以影响基因组结构及功能,还在早期胚胎发育中发挥重要的作用.本文综述了5hmC的代谢通路、生物学功能、在基因组的分布及分析方法的研究进展.     

哺乳动物TET2蛋白氧化5-甲基胞嘧啶的结构生物学研究

DNA甲基化是表现遗传学最重要的修饰之一,哺乳动物的DNA甲基化修饰主要发生在胞嘧啶第5位碳原子上,称为5-甲基胞嘧啶（5-methylcytosine,5mC）。     

TET家族蛋白介导的DNA氧化的调控与其生物学功能

发生在DNA胞嘧啶上的甲基化(5mC)是哺乳动物细胞基因组上最主要的DNA修饰形式,其形成的碳碳键具有较高键能,不易被破坏。TET家族蛋白可以催化5mC逐渐氧化成羟甲基胞嘧啶(5hmC)、醛基胞嘧啶(5fC)和羧基胞嘧啶(5caC),再通过细胞分裂过程中DNA复制,或者利用碱基切除修复途径,最终实现DNA去甲基化。过去几年表观基因组学和结构生物学的研究都表明,在不同细胞、不同的基因组位点,5mC的氧化反应受到严格的调控,主要表现在两个方面:5mC氧化反应发生的基因组范围和5mC逐步氧化反应的进行程度。以国家自然科学基金委重大研究计划"细胞编程和重编程的表观遗传机制"为依托,朱冰实验室发现了胚胎干细胞的多能性转录因子SALL4A与TET家族蛋白共同调节远端调控区域5mC的氧化过程。首先,将介绍5mC的不同氧化产物在小鼠基因组上的分布和动态变化,进而讨论TET家族蛋白催化5mC氧化反应的调控机制,最后,探讨5mC氧化参与调节基因组转录的可能的生物学功能。     

TET蛋白：一个新的DNA修饰酶家族

DNA的胞嘧啶（C）5-甲基化是一种重要的表观修饰,它参与基因调节、基因组印记、X-染色体失活、重复序列抑制和癌症发生等过程. 5-甲基胞嘧啶（5mC）可被TET (ten-eleven translocation)蛋白家族进一步转化为5-羟甲基胞嘧啶（5hmC）,该过程是DNA去甲基化的1个必要阶段. 5hmC可在活性转录基因起始位点和Polycomb抑制基因启动子延伸区域富集.TET蛋白包括3个成员TET1、TET2和TET3,均属于α-酮戊二酸和Fe²⁺依赖的双加氧酶,其催化涉及氧化过程.小鼠Tet1在胚胎干细胞发育中拥有双重作用,即促进全能因子的转录,又参与发育调节因子的抑制.人TET蛋白的破坏与造血系统肿瘤相关,如在骨髓增生性疾病/肿瘤存在频繁的TET2基因突变.TET蛋白和5hmC的研究为DNA甲基化/去甲基化及其生物学功能提供了新的视点.     

《核酸研究》:科学家提出基因水平碱基分析新方法

<正>中科院生态环境中心汪海林研究组在5-羟甲基胞嘧啶(5hmC)分析方面取得重要进展,提出了对该物质进行分析的新方法。相关成果近日发表于《核酸研究》(Nucleic Acids Research)。据了解,5hmC是科学家发现的第六种碱基,已在多种哺乳动物组织和细胞中检出。另外,多种肿瘤中5hmC水平偏低,使其有可能成为肿瘤     

Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer

Both 5-methylcytosine (5mC) and its oxidized form 5-hydroxymethylcytosine (5hmC) have been proposed to be involved in tumorigenesis. Because the readout of the broadly used 5mC mapping method, bisulfite sequencing (BS-seq), is the sum of 5mC and 5hmC levels, the 5mC/5hmC patterns and relationship of these two modifications remain poorly understood. By profiling real 5mC (BS-seq corrected by Tet-assisted BS-seq, TAB-seq) and 5hmC (TAB-seq) levels simultaneously at single-nucleotide resolution, we here demonstrate that there is no global loss of 5mC in kidney tumors compared with matched normal tissues. Conversely, 5hmC was globally lost in virtually all kidney tumor tissues. The 5hmC level in tumor tissues is an independent prognostic marker for kidney cancer, with lower levels of 5hmC associated with shorter overall survival. Furthermore, we demonstrated that loss of 5hmC is linked to hypermethylation in tumors compared with matched normal tissues, particularly in gene body regions. Strikingly, gene body hypermethylation was significantly associated with silencing of the tumor-related genes. Downregulation of IDH1 was identified as a mechanism underlying 5hmC loss in kidney cancer. Restoring 5hmC levels attenuated the invasion capacity of tumor cells and suppressed tumor growth in a xenograft model. Collectively, our results demonstrate that loss of 5hmC is both a prognostic marker and an oncogenic event in kidney cancer by remodeling the DNA methylation pattern.     

Mouse olfactory bulb methylome and hydroxymethylome maps reveal noncanonical active turnover of DNA methylation

Hydroxylation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) by TET enzymes presents a particular regulatory mechanism in the mammalian brain. However, although methylation and hydroxymethylation of cytosines in non-CpG contexts have been reported, these mechanisms remain poorly understood. Here, we applied TAB-seq and oxBS-seq selectively to detect 5hmC and 5mC at base resolution in olfactory bulb derived from female mice. We found that active turnover of 5mC to 5hmC occurred in both CpG and non-CpG contexts. Strikingly, we identified a different sequence preference for 5mC and 5hmC in a CH context, in which H = A, C, or T, TNCA/TC for 5mC and NNCA/T/CN for 5hmC. More importantly, we found that genes showing 5mC to 5hmC turnover showed only limited overlap in CpG and CH contexts, and that olfactory receptor genes were marked with higher turnover of 5mC to 5hmC in non-CpG context. Collectively, we identified an unexpected sequence preference for non-CpG hydroxymethylation and distinct target genes regulated by the turnover of 5mC to 5hmC in CpG and CH contexts.     

Accurate Measurement of 5-Methylcytosine and 5-Hydroxymethylcytosine in Human Cerebellum DNA by Oxidative Bisulfite on an Array (OxBS-Array)

The Infinium 450K Methylation array is an established tool for measuring methylation. However, the bisulfite (BS) reaction commonly used with the 450K array cannot distinguish between 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). The oxidative-bisulfite assay disambiguates 5mC and 5hmC. We describe the use of oxBS in conjunction with the 450K array (oxBS-array) to analyse 5hmC/5mC in cerebellum DNA. The “methylation” level derived by the BS reaction is the combined level of 5mC and 5hmC at a given base, while the oxBS reaction gives the level of 5mC alone. The level of 5hmC is derived by subtracting the oxBS level from the BS level. Here we present an analysis method that distinguishes genuine positive levels of 5hmC at levels as low as 3%. We performed four replicates of the same sample of cerebellum and found a high level of reproducibility (average r for BS = 98.3, and average r for oxBS = 96.8). In total, 114,734 probes showed a significant positive measurement for 5hmC. The range at which we were able to distinguish 5hmC occupancy was between 3% and 42%. In order to investigate the effects of multiple replicates on 5hmC detection we also simulated fewer replicates and found that decreasing the number of replicates to two reduced the number of positive probes identified by > 50%. We validated our results using qPCR in conjunction with glucosylation of 5hmC sites followed by MspI digestion and we found good concordance with the array estimates (r = 0.94). This experiment provides a map of 5hmC in the cerebellum and a robust dataset for use as a standard in future 5hmC analyses. We also provide a novel method for validating the presence of 5hmC at low levels, and highlight some of the pitfalls associated with measuring 5hmC and 5mC.     

Dynamic reprogramming of 5-hydroxymethylcytosine during early porcine embryogenesis

DNA active demethylation is an important epigenetic phenomenon observed in porcine zygotes, yet its molecular origins are unknown. Our results show that 5-methylcytosine (5mC) converts into 5-hydroxymethylcytosine (5hmC) during the first cell cycle in porcine in vivo fertilization (IVV), IVF, and SCNT embryos, but not in parthenogenetically activated embryos. Expression of Ten-Eleven Translocation 1 (TET1) correlates with this conversion. Expression of 5mC gradually decreases until the morula stage; it is only expressed in the inner cell mass, but not trophectoderm regions of IVV and IVF blastocysts. Expression of 5mC in SCNT embryos is ectopically distinct from that observed in IVV and IVF embryos. In addition, 5hmC expression was similar to that of 5mC in IVV cleavage-stage embryos. Expression of 5hmC remained constant in IVF and SCNT embryos, and was evenly distributed among the inner cell mass and trophectoderm regions derived from IVV, IVF, and SCNT blastocysts. Ten-Eleven Translocation 3 was highly expressed in two-cell embryos, whereas TET1 and TET2 were highly expressed in blastocysts. These data suggest that TET1-catalyzed 5hmC may be involved in active DNA demethylation in porcine early embryos. In addition, 5mC, but not 5hmC, participates in the initial cell lineage specification in porcine IVV and IVF blastocysts. Last, SCNT embryos show aberrant 5mC and 5hmC expression during early porcine embryonic development.     

Tet family proteins and 5-hydroxymethylcytosine in development and disease

Over the past few decades, DNA methylation at the 5-position of cytosine (5-methylcytosine, 5mC) has emerged as an important epigenetic modification that plays essential roles in development, aging and disease. However, the mechanisms controlling 5mC dynamics remain elusive. Recent studies have shown that ten-eleven translocation (Tet) proteins can catalyze 5mC oxidation and generate 5mC derivatives, including 5-hydroxymethylcytosine (5hmC). The exciting discovery of these novel 5mC derivatives has begun to shed light on the dynamic nature of 5mC, and emerging evidence has shown that Tet family proteins and 5hmC are involved in normal development as well as in many diseases. In this Primer we provide an overview of the role of Tet family proteins and 5hmC in development and cancer.     

Transient reduction of 5-methylcytosine and 5-hydroxymethylcytosine is associated with active DNA demethylation during regeneration of zebrafish fin

Although dedifferentiation, transformation of differentiated cells into progenitor cells, is a critical step in the regeneration of amphibians and fish, the molecular mechanisms underlying this process, including epigenetic changes, remain unclear. Dot blot assays and immunohistochemical analyses revealed that, during regeneration of zebrafish fin, the levels of 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) are transiently reduced in blastema cells and cells adjacent to the amputation plane at 30 h post-amputation (hpa), and the level of 5mC, but not 5hmC, is almost restored by 72 hpa. We observed that the dedifferentiated cells showed reduced levels of 5mC and 5hmC independent of cell proliferation by 24 hpa. Furthermore, expressions of the proposed demethylation- and DNA repair-related genes were detected during fin regeneration. Taken together, our findings illustrate that the transient reduction of 5mC and 5hmC in dedifferentiated cells is associated with active demethylation during regeneration of zebrafish fin.     

5‐Hydroxymethylcytosine: a new kid on the epigenetic block?

The discovery of the Ten‐Eleven‐Translocation (TET) oxygenases that catalyze the hydroxylation of 5‐methylcytosine (5mC) to 5‐hydroxymethylcytosine (5hmC) has triggered an avalanche of studies aiming to resolve the role of 5hmC in gene regulation if any. Hitherto, TET1 is reported to bind to CpG‐island (CGI) and bivalent promoters in mouse embryonic stem cells, whereas binding at DNAseI hypersensitive sites (HS) had escaped previous analysis. Significant enrichment/accumulation of 5hmC but not 5mC can indeed be detected at bivalent promoters and at DNaseI‐HS. Surprisingly, however, 5hmC is not detected or present at very low levels at CGI promoters notwithstanding the presence of TET1. Our meta‐analysis of DNA methylation profiling points to potential issues with regard to the various methodologies that are part of the toolbox used to detect 5mC and 5hmC. Discrepancies between published studies and technical limitations prevent an unambiguous assignment of 5hmC as a ‘true’ epigenetic mark, that is, read and interpreted by other factors and/or as a transiently accumulating intermediary product of the conversion of 5mC to unmodified cytosines.